This study is currently not recruiting participants.

Clinical Diagnosis of Oral/Pharyngeal Cancer by Ambient Mass Spectrometry

Investigation of Investigational Diagnostic Technology for Oral Cavity Cancer

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to develop and improve MS technology for point-of-care diagnosis, alternatives to current methods in oral cavity cancer.

Detailed description of study

The purpose of this study is to develop and improve MS technology for point-of-care diagnosis, alternatives to current methods in oral cavity cancer.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: oral cancer
  • Age: 100 years or below
  • Gender: All

This study investigates the use of MS technology for diagnosing oral cavity cancer at the point of care. Oral cavity cancer affects the mouth and throat area, and point-of-care diagnosis refers to medical testing conducted at or near the site of patient care.

Participants will undergo procedures to test the effectiveness of the MS technology compared to current diagnostic methods. MS technology stands for mass spectrometry, which is a technique used to measure the mass-to-charge ratio of ions.

  • Who can participate: Participants must be adults diagnosed with or at risk for oral cavity cancer.
  • Study details: Participants will be involved in testing investigational diagnostic technology. This may involve comparing results from the investigational technology with current diagnostic methods.
Updated on 19 Feb 2024. Study ID: 1504349676

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team